This site is intended for healthcare professionals only

PCRA Logo



Chiesi

Chiesi Limited is the UK affiliate of Chiesi Farmaceutici S.p.A. It is headquartered in Manchester and employs over 250 employees.

Chiesi Farmaceutici is an international research-focussed Healthcare Group based in Parma, Italy, with over 80 years of experience in the pharmaceutical industry. The group employs nearly 5,000 people and has affiliates in 26 countries, with its products reaching over 70 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas.

Its R&D organisation is also headquartered in Parma, Italy, and integrated with six other key R&D groups in France, the USA, the UK, Sweden and Denmark to advance Chiesi's pre-clinical, clinical and registration programmes. R&D remains a key priority for Chiesi, with the product pipeline increasingly leveraging novel, proprietary therapeutics that target diseases with high unmet medical need, with the ultimate aim of giving patients access to innovative medicines that improve quality of life.
Chiesi Limited is the UK affiliate of Chiesi Farmaceutici S.p.A. It is headquartered in Manchester and employs over 250 employees.

Chiesi Farmaceutici is an international research-focussed Healthcare Group based in Parma, Italy, with over 80 years of experience in the pharmaceutical industry. The group employs nearly 5,000 people and has affiliates in 26 countries, with its products reaching over 70 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas.

Its R&D organisation is also headquartered in Parma, Italy, and integrated with six other key R&D groups in France, the USA, the UK, Sweden and Denmark to advance Chiesi's pre-clinical, clinical and registration programmes. R&D remains a key priority for Chiesi, with the product pipeline increasingly leveraging novel, proprietary therapeutics that target diseases with high unmet medical need, with the ultimate aim of giving patients access to innovative medicines that improve quality of life.


Sponsored content



Media partners

Developed in partnership with

Funded by

Media partners:

This content, which is intended for UK healthcare professionals only, has been developed, funded and supplied to PCRA by Chiesi Ltd.